Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A new method to predict venous complications in pediatric liver transplantation: Evaluation of splenic parameters by ultrasonography

View through CrossRef
AbstractBackgroundVenous complications after pediatric liver transplantation seriously affect the survival rate of patients and grafts. At present, the diagnostic indicators have not been unified. Venous complications may cause portal hypertension, which may lead to splenomegaly and splenic vein dilatation. Therefore, the changes in spleen may be closely related to the venous complications. The purpose of this study was to explore the relationship between ultrasonic splenic parameters and venous complications and to study whether these splenic parameters can be used for the diagnosis of venous complications.MethodsWe retrospectively included pediatric patients who underwent liver transplantation and collected ultrasonic spleen parameters before, and then 1–3 days, 1–3 weeks, 1–3 months, and 4–12 months after liver transplantation. We observed whether there were portal vein or hepatic vein complications within 1 year after liver transplantation.ResultsAmong 109 pediatric patients after liver transplantation included in our study, 11 of them suffered from portal vein complications and nine hepatic vein complications. Spleen transverse diameter, spleen longitudinal diameter, spleen portal vein diameter, spleen index, spleen transverse diameter ratio, spleen longitudinal diameter ratio, and spleen index ratio were independent risk factors of venous complications. The accuracy of spleen transverse diameter (AUROC: 0.73), spleen index (AUROC: 0.70), spleen transverse diameter ratio (AUROC: 0.71), and spleen index ratio (AUROC: 0.72) in predicting venous complications were higher than other ones.ConclusionsUltrasonic examination is a common follow‐up method for pediatric patients after liver transplantation and the application of ultrasonic spleen parameters may be helpful to monitor venous complications.
Title: A new method to predict venous complications in pediatric liver transplantation: Evaluation of splenic parameters by ultrasonography
Description:
AbstractBackgroundVenous complications after pediatric liver transplantation seriously affect the survival rate of patients and grafts.
At present, the diagnostic indicators have not been unified.
Venous complications may cause portal hypertension, which may lead to splenomegaly and splenic vein dilatation.
Therefore, the changes in spleen may be closely related to the venous complications.
The purpose of this study was to explore the relationship between ultrasonic splenic parameters and venous complications and to study whether these splenic parameters can be used for the diagnosis of venous complications.
MethodsWe retrospectively included pediatric patients who underwent liver transplantation and collected ultrasonic spleen parameters before, and then 1–3 days, 1–3 weeks, 1–3 months, and 4–12 months after liver transplantation.
We observed whether there were portal vein or hepatic vein complications within 1 year after liver transplantation.
ResultsAmong 109 pediatric patients after liver transplantation included in our study, 11 of them suffered from portal vein complications and nine hepatic vein complications.
Spleen transverse diameter, spleen longitudinal diameter, spleen portal vein diameter, spleen index, spleen transverse diameter ratio, spleen longitudinal diameter ratio, and spleen index ratio were independent risk factors of venous complications.
The accuracy of spleen transverse diameter (AUROC: 0.
73), spleen index (AUROC: 0.
70), spleen transverse diameter ratio (AUROC: 0.
71), and spleen index ratio (AUROC: 0.
72) in predicting venous complications were higher than other ones.
ConclusionsUltrasonic examination is a common follow‐up method for pediatric patients after liver transplantation and the application of ultrasonic spleen parameters may be helpful to monitor venous complications.

Related Results

[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Liver and Pancreas Transplantation
Liver and Pancreas Transplantation
More than 6,000 liver transplantations are performed annually in the United States. Enhancements in patient selection and surgical technique and the availability of more powerful i...
Spleen-preserving pancreatectomy with splenic vessels removal : impact on splenic parenchyma ?
Spleen-preserving pancreatectomy with splenic vessels removal : impact on splenic parenchyma ?
Abstract Background While outcomes after spleen-preserving distal pancreatectomy (SP-DP) are widely reported, the impact on splenic parenchyma is poorly studied. This study...
Reduction of the Recipient Spleen Size After Living Donor Liver Transplantation A Retrospective Study.
Reduction of the Recipient Spleen Size After Living Donor Liver Transplantation A Retrospective Study.
Abstract Background: Liver transplantation is considered an important solution to patients with end stage liver disease and a glimpse of hope for some patients with terribl...
Reduction of Recipient Spleen Size after Living Donor Liver Transplantation: A Retrospective Study
Reduction of Recipient Spleen Size after Living Donor Liver Transplantation: A Retrospective Study
Abstract Background Liver transplantation is considered an important solution to patients with end stage liver disease and a gli...

Back to Top